This video demonstrates a Florida sleeve valve-sparing aortic root repair, repair of the leaking bicuspid valve with raphe shaving, virtual basal ring annuloplasty and leaflet plication, and ascending through proximal arch replacement with alternate aortic cannulation/clamping.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Valve Disease
October 5, 2015
Pts undergoing cardiac surgery requiring CPB were randomized to remote ischemic preconditioning of the upper extremity or sham intervention. The end point was combined death, MI, stroke, and acute renal failure during hospitalization, and secondary endpoints were the occurrence of any such event within 90 days. Outcomes were similar between the gro
October 5, 2015
Patients entered into a clinical trial of TAVR and patients in two registries were evaluated for possible subclinical leaflet thrombosis in their bioprosthetic valves. 40% of the patients in the TAVR trial and 13% of registry patients were found to have such thrombosis. The risk was lower in patients anticoagulated with warfarin. Therpeutic antico
September 30, 2015
Ischemic mitral regurgitation (IMR) is a subset of functional mitral regurgitation (MR) that has the potential to impact an increasing number of patients in the future. This is in the context of a worldwide population, which continues to live longer with improved survival after myocardial infarction.
September 29, 2015
Vinnie Bapat of Guys and St. Thomas’ Hospital, London, UK, discusses the Edwards FORTIS device, a transcatheter mitral valve device.
September 28, 2015
This video shows a robotic-assisted repair of an anterior mitral valve leaflet perforation from endocarditis and ruptured posterior chordae tendinae.
September 26, 2015
In this RCT, patients at increased risk for cardiac surgery requiring CPB were assigned to steroids at the time of anesthetic induction and again at the time of CPB induction or no steroids. Primary outcomes were 30-day mortality and major morbidity. Steriods had no effect on the primary outcomes. There was no evidence that stero
September 24, 2015
Neil Moat of the Royal Brompton Hospital, London, UK, gives a talk on transcatheter mitral valve implantation.
September 23, 2015
The authors conducted a propensity-matched analysis of outcomes and costs associated with TAVR vs. SAVR procedures in patients considered either intermediate risk (STS PROM 4-8%) or high risk (STS PROM >8%) within the Commonwealth of Virginia.
September 18, 2015
This study describes activity and outcomes for both standard aortic valve implantation and transcatheter aortic valve implantation (TAVI) in England and Wales in the TAVI era. The study demonstrates that both standard aortic valve implantation and TAVI acitivity have increased since TAVI was first performed in the United Kingdom.